84 related articles for article (PubMed ID: 17412712)
1. Mutator pathways unleashed by epigenetic silencing in human cancer.
Jacinto FV; Esteller M
Mutagenesis; 2007 Jul; 22(4):247-53. PubMed ID: 17412712
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of ID4 in the determination of the BRCAness phenotype in breast cancer.
Branham MT; Campoy E; Laurito S; Branham R; Urrutia G; Orozco J; Gago F; Urrutia R; Roqué M
Breast Cancer Res Treat; 2016 Jan; 155(1):13-23. PubMed ID: 26610810
[TBL] [Abstract][Full Text] [Related]
3. Gene silencing in DNA damage repair.
Soejima H; Joh K; Mukai T
Cell Mol Life Sci; 2004 Sep; 61(17):2168-72. PubMed ID: 15338047
[TBL] [Abstract][Full Text] [Related]
4. Constitutional
Al-Moghrabi N; Al-Showimi M; Alqahtani A; Almalik O; Alhusaini H; Almalki G; Saad A; Alsunayi E
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542081
[TBL] [Abstract][Full Text] [Related]
5. Checkpoint Kinase 1 (CHK1) Functions as Both a Diagnostic Marker and a Regulator of Epithelial-to-Mesenchymal Transition (EMT) in Triple-Negative Breast Cancer.
Kim HJ; Seo BG; Seo EC; Lee KM; Hwangbo C
Curr Issues Mol Biol; 2022 Nov; 44(12):5848-5865. PubMed ID: 36547059
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-126 expression in the peripheral white blood cells of patients with breast and ovarian cancer is a potential biomarker for the early prediction of cancer risk in the carriers of methylated
Al-Showimi M; Al-Yousef N; Alharbi W; Alkhezayem S; Almalik O; Alhusaini H; Alghamdi A; Al-Moghrabi N
Oncol Lett; 2022 Aug; 24(2):276. PubMed ID: 35782895
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic Identification of Anticancer Metabolites of Australian Propolis and Proteomic Elucidation of Its Synergistic Mechanisms with Doxorubicin in the MCF7 Cells.
Alsherbiny MA; Bhuyan DJ; Radwan I; Chang D; Li CG
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360606
[TBL] [Abstract][Full Text] [Related]
8.
Al-Moghrabi NM
J Taibah Univ Med Sci; 2017 Jun; 12(3):189-193. PubMed ID: 31435238
[TBL] [Abstract][Full Text] [Related]
9. Methylation of BRCA1 and MGMT genes in white blood cells are transmitted from mothers to daughters.
Al-Moghrabi N; Al-Showimi M; Al-Yousef N; Al-Shahrani B; Karakas B; Alghofaili L; Almubarak H; Madkhali S; Al Humaidan H
Clin Epigenetics; 2018 Jul; 10(1):99. PubMed ID: 30049288
[TBL] [Abstract][Full Text] [Related]
10. The mutagen and carcinogen cadmium is a high-affinity inhibitor of the zinc-dependent MutLα endonuclease.
Sherrer SM; Penland E; Modrich P
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):7314-7319. PubMed ID: 29941579
[TBL] [Abstract][Full Text] [Related]
11. Can 5-methylcytosine analogues with extended alkyl side chains guide DNA methylation?
Kotandeniya D; Seiler CL; Fernandez J; Pujari SS; Curwick L; Murphy K; Wickramaratne S; Yan S; Murphy D; Sham YY; Tretyakova NY
Chem Commun (Camb); 2018 Jan; 54(9):1061-1064. PubMed ID: 29323674
[TBL] [Abstract][Full Text] [Related]
12. DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial.
Wolf DM; Yau C; Sanil A; Glas A; Petricoin E; Wulfkuhle J; Severson TM; Linn S; Brown-Swigart L; Hirst G; Buxton M; DeMichele A; Hylton N; Symmans F; Yee D; Paoloni M; Esserman L; Berry D; Rugo H; Olopade O; van 't Veer L
NPJ Breast Cancer; 2017; 3():31. PubMed ID: 28948212
[TBL] [Abstract][Full Text] [Related]
13. Interaction of proliferating cell nuclear antigen with PMS2 is required for MutLα activation and function in mismatch repair.
Genschel J; Kadyrova LY; Iyer RR; Dahal BK; Kadyrov FA; Modrich P
Proc Natl Acad Sci U S A; 2017 May; 114(19):4930-4935. PubMed ID: 28439008
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms in E. coli and Human Mismatch Repair (Nobel Lecture).
Modrich P
Angew Chem Int Ed Engl; 2016 Jul; 55(30):8490-501. PubMed ID: 27198632
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic modifiers in immunotherapy: a focus on checkpoint inhibitors.
Terranova-Barberio M; Thomas S; Munster PN
Immunotherapy; 2016 Jun; 8(6):705-19. PubMed ID: 27197539
[TBL] [Abstract][Full Text] [Related]
16. HDAC4, a prognostic and chromosomal instability marker, refines the predictive value of MGMT promoter methylation.
Cheng W; Li M; Cai J; Wang K; Zhang C; Bao Z; Liu Y; Wu A
J Neurooncol; 2015 Apr; 122(2):303-12. PubMed ID: 25557107
[TBL] [Abstract][Full Text] [Related]
17. MGMT testing--the challenges for biomarker-based glioma treatment.
Wick W; Weller M; van den Bent M; Sanson M; Weiler M; von Deimling A; Plass C; Hegi M; Platten M; Reifenberger G
Nat Rev Neurol; 2014 Jul; 10(7):372-85. PubMed ID: 24912512
[TBL] [Abstract][Full Text] [Related]
18. Writing and rewriting the epigenetic code of cancer cells: from engineered proteins to small molecules.
Blancafort P; Jin J; Frye S
Mol Pharmacol; 2013 Mar; 83(3):563-76. PubMed ID: 23150486
[TBL] [Abstract][Full Text] [Related]
19. The significance of epigenetic alterations in lung carcinogenesis.
Brzeziańska E; Dutkowska A; Antczak A
Mol Biol Rep; 2013 Jan; 40(1):309-25. PubMed ID: 23086271
[TBL] [Abstract][Full Text] [Related]
20. Environmental toxicants, epigenetics, and cancer.
Pogribny IP; Rusyn I
Adv Exp Med Biol; 2013; 754():215-32. PubMed ID: 22956504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
